Longwood Fund

Venture Capital · Boston (United States) · Founded 2010

About

Longwood creates and invests in science-based companies that develop novel solutions for important medical problems.

Investment Stages

Series A, Series B

Industry Focus

BioTech, Healthcare

Portfolio Companies

Evommune, Weaver, Xaira, Progentos, Bbot, Engrail, Doppler, Solu, AAVantgarde, DEM, Carbon, Photys, Rectify, Interius, Xylocor, Be Bio, Immunitas Therapeutics, Pyxis Oncology, Lassen Therapeutics, Werewolf, TScan, Archer, Sitryx, Bicycle Therapeutics, Grail, Pulmocide, Axial Therapeutics, Millendo Therapeutics, Channel Medsystems, Kalvista Pharmaceuticals, Colorescience, Calithera Biosciences, Mitobridge, Illuminoss, Verastem, PTC Therapeutics, Alnara

Team (7)

Aleks Radovic-Moreno - Partner
Annie Vemu - Senior Associate
Christoph Westphal - Co-Founder & General Partner
Lucy Liu - Principal
Rich Aldrich - Founding Partner
Vikas Goyal - Partner
Lizzie Ngo - Principal